JPMorgan Healthcare Leaders ETF (JDOC)

Assets	$7.66M
Expense Ratio	0.65%
PE Ratio	22.43
Shares Out	150,000
Dividend (ttm)	$2.82
Dividend Yield	5.55%
Ex-Dividend Date	Dec 24, 2024
Payout Frequency	Semi-Annual
Payout Ratio	124.89%

Volume	17
Open	49.78
Previous Close	50.70
Day's Range	49.78 - 49.78
52-Week Low	47.67
52-Week High	63.49
Beta	n/a
Holdings	62
Inception Date	Nov 1, 2023

About JDOC

Fund Home Page

The JPMorgan Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: JDOC
• ETF Provider: JPMorgan Chase

Top 10 Holdings

45.64% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	7.75%
Johnson & Johnson	JNJ	6.61%
AbbVie Inc.	ABBV	6.02%
UnitedHealth Group Incorporated	UNH	4.55%
AstraZeneca PLC	AZN	4.11%
Boston Scientific Corporation	BSX	4.11%
Stryker Corporation	SYK	3.52%
Danaher Corporation	DHR	3.29%
McKesson Corporation	MCK	2.97%
Vertex Pharmaceuticals Incorporated	VRTX	2.71%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 24, 2024	$0.3276	Dec 27, 2024
Dec 16, 2024	$2.48902	Dec 18, 2024
Dec 19, 2023	$0.07965	Dec 22, 2023

Performance

JDOC had a total return of -10.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.10%.